Pulmonary Fibrosis News

Home
United States
Dallas, TX
Pulmonary Fibrosis News

We are dedicated to sharing the latest news, research, and pulmonary fibrosis patient perspectives.

08/06/2025

GRI-0621 appears to reduce markers of fibrosis in people with idiopathic pulmonary fibrosis, interim clinical trial data suggest. https://buff.ly/NcHD0FF

08/05/2025

Columnist Sam Kirton finds that filling the silence is part of living with a chronic condition, especially amid retirement and COVID-19. https://buff.ly/45FmTTb

07/30/2025

Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic pulmonary fibrosis. https://buff.ly/HnrilMF

07/29/2025

Columnist Sam Kirton describes how daunting an IPF prognosis can be — but also how things are looking up for patients today. https://buff.ly/GzVg08L

07/22/2025

A flash flood can pose unique risks for PF patients, says columnist Sam Kirton, who shares several ways to prepare for such an emergency. https://buff.ly/RGq13co

07/18/2025

Taladegib has been granted orphan drug designation in the U.S. and the European Union as a treatment for idiopathic pulmonary fibrosis. https://buff.ly/SYKwyfY

07/15/2025

Columnist Sam Kirton had to make some adjustments after his IPF diagnosis, but there are still plenty of ways to find joy, he says. https://buff.ly/nOjlX7C

07/11/2025

GRI-0621, an experimental oral therapy for IPF, has so far been tolerated well in an ongoing Phase 2 clinical trial. https://buff.ly/9TggTc1

07/10/2025

Columnist Sam Kirton marks four years since his bilateral lung transplant by reflecting on his health, his family, and his donor's legacy. https://buff.ly/WdjRnrp

07/01/2025

Because certain IPF and post-transplant medications can cause sun sensitivity, skin protection is crucial, says columnist Sam Kirton. https://buff.ly/6yEm92f

06/27/2025

A Texas researcher received a $219,000 NIH grant to study the potential of a treatment for radiation-induced pulmonary fibrosis. https://buff.ly/9GJuNtF

06/24/2025

Clinical trials are an important part of IPF research, says columnist Sam Kirton, but we need people willing to participate in them. https://buff.ly/qL18G7j

Address

5307 E Mockingbird Lane
Dallas, TX
75206

Telephone

+12143797441

Website

http://pulmonaryfibrosisnews.com/

Alerts

Be the first to know and let us send you an email when Pulmonary Fibrosis News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.